BlackRock Institutional Trust’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$2.24M	Buy	203,920 +31,032	+18%	+$341K	﹤0.01%	3010
2016 Q3	$2.71M	Buy	172,888 +7,264	+4%	+$114K	﹤0.01%	2934
2016 Q2	$1.69M	Buy	165,624 +107,706	+186%	+$1.1M	﹤0.01%	3095
2016 Q1	$747K	Buy	57,918 +25,477	+79%	+$329K	﹤0.01%	3348
2015 Q4	$677K	Buy	+32,441	New	+$677K	﹤0.01%	3423